Skip to main content

Table 2 List of papers included in analysis, arranged in date order (most recent first) with PubMed PMID reference numbers

From: Evidence-based practice in Behçet’s disease: identifying areas of unmet need for 2014

  Title Published PubMed PMID
[10] Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis 2013 23314623
[11] Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials 23290985
[12] Clinical background comparison of patients with and without ocular inflammatory attacks after initiation of infliximab therapy 2012 23053631
[13] Multicenter study of infliximab for refractory uveoretinitis in Behçet disease 22652845
[14] A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behçet’s disease: a comparative 4-week study 2011 21097877
[15] One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet’s disease refractory to standard immunosuppressive drugs 19859715
[16] Azathioprine in severe uveitis of Behçet’s disease 2010 20665749
[17] Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease 20545993
[18] Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behçet’s disease 20704623
[19] Pimecrolimus versus placebo in genital aphthous ulcers of Behcet’s disease: a randomized double-blind controlled trial 20704622
[20] Rituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study) 19692382
[21] Colchicine versus placebo in Behçet’s disease: randomized, double-blind, controlled crossover trial 2009 19076988
[22] Effectiveness and safety of endovascular aneurysm treatment in patients with vasculo-Behçet disease 19717547
[23] Low-dose natural human interferon-alpha lozenges in the treatment of Behçet’s syndrome 19842735
[24] Randomized trial of pimecrolimus cream plus colchicine tablets versus colchicine tablets in the treatment of genital ulcers in Behçet’s disease 19434815
[25] Relationship between periodontal parameters and Behçet’s disease and evaluation of different treatments for oral recurrent aphthous stomatitis 19320802
[26] The close association between dental and periodontal treatments and oral ulcer course in behcet’s disease: a prospective clinical study 19060462
[27] Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-α level in patients with mucocutaneous type of Behcet’s disease 19597921
[28] Behçet’s disease: comparing 3 decades of treatment response at the National Eye Institute 2008 18929351
[29] Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease 18711463
[30] Interrelated modulation of endothelial function in Behcet’s disease by clinical activity and corticosteroid treatment 2007 17845731
[31] A double-blind trial of depot corticosteroids in Behçet’s syndrome 2006 17067433
[32] Lactobacilli lozenges in the management of oral ulcers of Behçet’s syndrome 16923135
[33] Oral zinc sulfate in the treatment of Behcet’s disease: a double blind cross-over study 16263779
[34] Colchicine and benzathine penicillin in the treatment of Behçet disease: a case comparative study 2005 16409899
[35] Short-term trial of etanercept in Behçet’s disease: a double blind, placebo controlled study 16321889
[36] Vitrectomy for persistent panuveitis in Behçet’s disease 15630733
[37] Abdominal aortic aneurysm in Behçet’s disease: new treatment options for an old and challenging problem 2004 15079762
[38] Differential efficacy of human recombinant interferon-α2a on ocular and extraocular manifestations of behçet disease: results of an open 4-center trial 14996689
[39] Infliximab for recurrent, sight-threatening disease in Adamantiades-Behcet disease 15055270
[40] Clinical study on therapeutic effect of acupuncture on Behcet’s disease 2003 14719295
[41] Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet’s disease: a randomised, double-blind, placebo-controlled study 12928692
[42] Evaluation of the effect of acetazolamide on cystoid macular oedema in patients with Behcet’s disease 12918754
[43] Dapsone in Behçet’s disease: a double-blind, placebo-controlled, cross-over study 2002 12568631
[44] A double-blind trial of colchicine in Behçet’s syndrome 2001 12081158
[45] Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet’s disease 11935432
[46] Short-term chlorambucil for refractory uveitis in Behcet’s disease 11710724
[47] Ciclosporin Microemulsion Preconcentrate Treatment of Patients With Behçet’s Disease 1999 11752821
[48] Effects of interferon-alpha2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis factor-alpha2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behçet’s disease 10482480
[49] The Use of Sucralfate Suspension in the Treatment of Oral and Genital Ulceration of Behchet Disease 10328192
[50] Thalidomide in the Treatment of the Mucocutaneous Lesions of the Behcet Syndrome 1998 10651074
[51] Treatment of Adamantiades-Behçet disease with systemic interferon alfa 9722733
[52] Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet’s disease 1996 9499327
[53] Interferon alfa-2a in the treatment of Behçet’s disease 8829493
[54] A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet’s disease and allied conditions 1995 8594659
[55] Inefficacy of azapropazone in the acute arthritis of Behçet’s syndrome: a randomized, double blind, placebo controlled study 7586783
[56] Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet’s disease: use of neurophysiological studies to detect thalidomide neuropathy 1994 7864692
[57] Systemic interferon alpha 2b treatment in Behçet’s syndrome 7932420
[58] Visual prognosis in patients with Behçet’s disease receiving colchicine, systemic corticosteroid or cyclosporin 7970549
[59] Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet’s syndrome: a single masked trial 1992 1390495
[60] Desensitization by autologous saliva and Behçet’s disease 1991 1913022
[61] Effect of cyclosporine A on the hearing loss in Behçet’s disease 1771312
[62] Inefficacy of Topical Alpha Interferon in the Treatment of Oral Ulcers of Behcet’s Syndrome: a Randomized Double Blind Trial 2058987
[63] Long-term effects of cyclophosphamide and colchicine treatment in Behçet’s disease 2064258
[64] Treatment of Behçet disease with indomethacin 1993568
[65] A controlled trial of azathioprine in Behcet’s syndrome 1990 2404204
[66] Topical alpha interferon in the treatment of oral ulcers in Behçet’s syndrome: a preliminary report 2189624
[67] Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in behcet’s disease 1989 2566048
[68] Evaluation of conventional therapy versus cyclosporine A in Behçet’s syndrome 1988 3044474
[69] Treatment with aciclovir does not affect orogenital ulcers in Behcet’s syndrome: a randomised double-blind trial 3381269
  1. Full list of references included at end of main text[1069].